N. SCOTT FINE - 20 Apr 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Executive Officer, Director
Signature
/s/ N. Scott Fine
Issuer symbol
CYTH
Transactions as of
20 Apr 2023
Net transactions value
+$250,001
Form type
4
Filing time
24 Apr 2023, 10:28:30 UTC
Previous filing
09 Mar 2023
Next filing
23 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Purchase $212,575 +299,402 +206% $0.7100 444,402 20 Apr 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Warrant to Purchase Common Stock Purchase $37,425 +299,402 $0.1250* 299,402 20 Apr 2023 Common Stock 299,402 $0.7100 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.